Palisade Bio (PALI) Revenue (2011 - 2023)
Palisade Bio (PALI) reported Revenue of $250000.0 for Q1 2023, up 9900.0% quarter-over-quarter from $2500.0 in Q4 2020.
Palisade Bio (PALI) Revenue (2011 - 2023) Analysis & Trends
Palisade Bio (PALI) has 11 years of Revenue data on file, last reported at $250000.0 in Q1 2023.
- Revenue for Q1 2023 came in at $250000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $250000.0 (changed N/A YoY), and the FY2023 annual result was $250000.0, changed N/A from the prior year.
- Revenue advanced to $250000.0 in Q1 2023 per PALI's latest filing, from $2500.0 in the prior quarter.
- Over five years, Revenue peaked at $250000.0 in Q1 2023 and troughed at $2500.0 in Q1 2019.
- A 3-year average of $30990.4 and a median of $2500.0 in 2019 frame the typical range for Revenue.
- The sharpest annual moves came in 2019 and 2020: Revenue tumbled 96.87% in 2019, then jumped 140.8% in 2020.
- A 3-year view of Revenue shows it stood at $2500.0 in 2019, then changed by 0.0% to $2500.0 in 2020, then surged by 9900.0% to $250000.0 in 2023.
- Business Quant data shows PALI's Revenue at $250000.0 in Q1 2023, $2500.0 in Q4 2020, and $2500.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2020 | 2,500.00 |
| Sep 30, 2020 | 2,500.00 |
| Jun 30, 2020 | 2,500.00 |
| Mar 31, 2020 | 6,020.00 |
| Dec 31, 2019 | 2,500.00 |
| Sep 30, 2019 | 2,500.00 |
| Jun 30, 2019 | 7,894.00 |
| Mar 31, 2019 | 2,500.00 |
| Dec 31, 2018 | 2,500.00 |
| Sep 30, 2018 | 2,500.00 |
| Jun 30, 2018 | 252,500.00 |
| Mar 31, 2018 | 2,500.00 |
| Dec 31, 2017 | 252,500.00 |
| Sep 30, 2017 | 2,500.00 |
| Jun 30, 2017 | 2,500.00 |
| Mar 31, 2017 | 2,500.00 |
| Dec 31, 2016 | 8,746.00 |
| Sep 30, 2016 | 2,500.00 |
| Jun 30, 2016 | 2,500.00 |